logo
Moldy burgers, impaired senses, tap dancing highlight 61st Howard County Science Fair

Moldy burgers, impaired senses, tap dancing highlight 61st Howard County Science Fair

Yahoo17-02-2025

Ever wondered what fast food burger has the best ingredients?
That was the question Mukhil Madhan posed for his science fair project.
To determine this, the Western seventh grader put burgers from restaurants in clear, plastic containers and let them sit for four weeks. He then observed the amount of mold that grew on each.
One burger had lots of mold. That's a good sign. The burger from another local fast food restaurant, however, looked nearly the same.
'The bacteria and stuff doesn't want to eat that,' said Hannah Sandefur, Mukhil's science teacher.
'Moldy Burgers' was one of the projects presented at Saturday's 61st annual Howard County Science Fair.
The event featured students from Eastern and Western.
That included Western Middle School students Sienna Osborn and Savana Halterman. They looked at how impairing senses impacted a person's ability to discern flavors. To do so, they had people taste Skittles and then repeated the process blindfolding them, then plugging their nose and lastly, removing both senses.
Surprisingly, almost half of people struggled to identify the correct flavor when blindfolded.
'I think a lot of people relied on seeing the color and recognizing the color as the flavor,' Savana said.
More than one in three people — ranging from kids to adults — could not guess the flavor when both of their senses were impaired.
They got the idea for their Skittles taste test experiment from a TV show.
'One thing I would do is boys versus girls, see if they have different taste buds,' Sienna said.
For their efforts, Savana and Sienna were first-prize winners. They received a cash prize.
'It was fun, but it was a big test,' Sienna said. 'I would do it again.'
Ethan Faulkner and Jude Siscel tested if other types of oil could replace petroleum in a two-stroke engine. The boys tested castor, hydraulic and soybean oils.
'We found out castor is probably most reliable,' Jude said.
Castor oil is a vegetable oil that comes from castor beans.
The two listened to the engine of an old chainsaw as they tested the different oils.
'We learned the effects of not having a compressible oil,' Jude said.
Castor oil came out on top.
'Made the engine smoke less,' Ethan said.
Soybean oil, on the other hand, did not.
'The entire barn smelled like beans for a week,' Jude said.
The boys said if their project had a next step it would be testing the long-term effects of using those oils. They enjoyed sharing their results with the judges Saturday.
'I didn't know talking to a bunch of people about two-stroke engines would be fun,' Jude said.
Other projects included Sadie Weeks' look at what surface produced the loudest sound when wearing tap dancing shoes and Corbin Perryman testing the effects of freezing and boiling temperatures had on a magnet's ability to pick up paper clips.
The science fair is held each year at Indiana University Kokomo. Staff, faculty, alumni and students served as judges, interviewing students about their projects.
'I think the kids who are participating in science fair love science,' said Deb Jaworski, science fair committee member and IUK math lecturer. 'It's become very contagious.'
She said many of the students she judged wanted to do the science fair again.
Absent on Saturday were high school science fair projects. Linda Wilson and her Northwestern students have been a mainstay of the science fair for years, however the teacher retired at the end of last school year. Some of her students went on to show their projects at the International Science Fair.
She is now an adjunct teacher at IUK and helped judge projects Saturday.
The Howard County Science Fair was once a widely attended event by all schools in the county, but it has dwindled over the years.
This is the first year in awhile Western has had a presence, thanks to Sandefur.
Sandefur and her students worked after school every Friday for months on their projects. She intends to include both seventh and eighth graders next year.
'It builds questions,' she said.
Sarah Bonesteel at Eastern takes the lead in helping those students with their projects.
'She has such energy and enthusiasm for science,' Jaworski said.
Science fair participants did a microscope lab with IUK faculty as part of the day's activities.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal
AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal

Yahoo

time4 hours ago

  • Yahoo

AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal

AstraZeneca has joined the long list of big pharma companies enlisting the services of Chinese biotechs, signing a deal worth up to $5.2bn with CSPC Pharmaceuticals to research chronic disease drug candidates. Under the deal, AstraZeneca will pay an upfront fee of $110m, along with milestone payments of $1.62bn. CSPC are also in line to receive $3.6bn in sales milestone payments. AstraZeneca and CSPC will discover and develop pre-clinical candidates for multiple targets, which, according to the companies, will have the 'potential to treat diseases across chronic indications, including a pre-clinical small molecule oral therapy for immunological diseases'. CSPC will use its AI-powered drug discovery platform, which uses the technology to analyse the binding patterns of target proteins with existing compound molecules. The AI models work out targeted optimisation, advancing small molecules with the best developability. For any candidates identified via the research partnership, AstraZeneca will have the right to exercise options for exclusive licences to develop and commercialise candidates worldwide. AstraZeneca's executive vice president and biopharmaceuticals R&D head Sharon Barr said: 'This strategic research collaboration underscores our commitment to innovation to tackle chronic diseases, which impact over two billion people globally. 'Forming strong collaborations allows us to leverage our complementary scientific expertise to support the rapid discovery of high-quality novel therapeutic molecules to deliver the next-generation medicines.' The partnership marks the second time this year AstraZeneca has invested resources in China. In March 2025, the drugmaker revealed plans to infuse $2.5bn over the next five years in Beijing to establish an R&D hub. China is enjoying a fruitful alliance with Western big pharma companies, despite a frosty relationship with US President Trump's administration, mainly due to the BIOSECURE ACT, which is admittedly now in legislative limbo. Licensing deals between US and Chinese biopharma companies hit record highs last year, up 280% from 2020, according to analysis by GlobalData. Across big pharma, transactions rose 66% from $16.6bn in 2023 to $41.5bn in 2024, demonstrating that China is still the go-to place to discover pipeline candidates. For deals specific to US companies, the analysis found that total deal value rose from $15.7bn in 2023 to $21.3bn in 2024. GlobalData is the parent company of Pharmaceutical Technology. "AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

China's AI chip tool QiMeng beats engineers, designs processors in just days
China's AI chip tool QiMeng beats engineers, designs processors in just days

Yahoo

timea day ago

  • Yahoo

China's AI chip tool QiMeng beats engineers, designs processors in just days

As the US-China tech war intensifies, both nations are racing to secure independence in critical technologies. With Washington tightening access to advanced chip tools, Beijing is ramping up efforts to break its reliance on Western software. In a major step, China's top scientific body has unveiled a homegrown, AI-powered system to automate chip design, an area long dominated by American firms. The Chinese Academy of Sciences (CAS) has launched an AI-driven chip design platform called QiMeng, meaning 'enlightenment' in Chinese. Developed by the State Key Laboratory of Processor, the Intelligent Software Research Centre, and the University of the Chinese Academy of Sciences, the system aims to accelerate semiconductor development and reduce dependency on human programmers. QiMeng leverages large language models to automate complex chip design tasks. The developers open-sourced the system on GitHub and published detailed technical documentation in a recent research paper. The team added that an autonomous-driving chip, which would take human engineers weeks to complete, could be produced by QiMeng in just a few days. QiMeng is built around three functional layers. The foundation is a domain-specific processor chip model. Above that is a design agent that handles both hardware and software aspects. The top layer contains various chip design applications. These components work together to support automated front-end design, generation of hardware description language, OS configuration, and compiler toolchain creation. The research paper notes that future iterations will boost the system's capacity for self-evolution. Using the platform, researchers have built two processors: QiMeng-CPU-v1, which is comparable to Intel's 486 chip, and QiMeng-CPU-v2, which aligns with Arm's Cortex A53. The launch of QiMeng comes at a time when the US is pressuring major electronic design automation (EDA) software vendors to stop selling to Chinese firms. Companies like Synopsys, Cadence, and Siemens EDA, who together held 82% of China's EDA market last year, have been hit by fresh export restrictions from the US Commerce Department, according to a Morgan Stanley report cited by SCMP. QiMeng is a direct attempt to replace reliance on these Western firms. 'The goal was to improve efficiency, reduce costs and shorten development cycles when compared to manual methods,' said the CAS team in their paper. The system also aims to enable rapid customisation of domain-specific chip architectures and software stacks. As AI advances demand more powerful chips, China's ability to design and fabricate them locally becomes crucial. While the country still lags behind Taiwan Semiconductor Manufacturing Company in advanced chip fabrication, efforts like QiMeng are intended to close the gap in design capabilities. The developers acknowledged remaining hurdles, citing 'constrained fabrication technology, limited resources and a diverse ecosystem.' Still, they hope QiMeng will help automate the full chip design and verification process in the long run.

Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025
Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025

Business Wire

timea day ago

  • Business Wire

Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced it will host a conference call and webcast on Tuesday, June 17, 2025, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to report results for its fiscal year 2025 ended March 31, 2025, and provide a corporate update. The conference call is being webcast live, and a link can be found under 'Events' in the Investors section of the Company's website. Participants may register to join the live call by following the link here to receive the dial-in numbers and unique PIN to access the call. Those who plan on participating are advised to join 15 minutes prior to the start time. A webcast replay of the call will be available on Vistagen's website about 24 hours after the end of the live conference call and will be accessible for at least 30 days. About Vistagen Headquartered in South San Francisco, CA, Vistagen (Nasdaq: VTGN) is a late clinical-stage biopharmaceutical company leveraging a deep understanding of nose-to-brain neurocircuitry to develop and commercialize a broad and diverse pipeline of clinical-stage product candidates from a new class of intranasal product candidates called pherines. Pherines specifically and selectively bind as agonists to peripheral receptors on human nasal chemosensory neurons and are designed to rapidly activate olfactory bulb-to-brain neurocircuits believed to regulate brain areas involved in behavior and autonomic nervous system activity. They are designed to achieve therapeutic benefits without requiring absorption into the blood or uptake into the brain, giving them the potential to be a safer alternative to other pharmacological options if successfully developed and approved. Vistagen's neuroscience pipeline also includes an oral prodrug with potential to treat certain neurological conditions involving the NMDA receptor. Vistagen is passionate about developing transformative treatment options to improve the lives of individuals underserved by the current standard of care for multiple highly prevalent indications, including social anxiety disorder, major depressive disorder, and multiple women's health conditions, including vasomotor symptoms (hot flashes) associated with menopause. Connect at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store